LPL Financial
GILD icon

LPL Financial’s Gilead Sciences GILD Stock Holding History

LPL Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$334K Buy
+2,400
New +$336K ﹤0.01% 5117
2025
Q3 		– Sell
-2,200
Closed -$244K – 5879
2025
Q2 		$244K Sell
2,200
-1,000
-31% -$106K ﹤0.01% 4936
2025
Q1 		$359K Buy
+3,200
New +$330K ﹤0.01% 4458

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

LPL Financial's GILD Position: Q1 2026 in Review

LPL Financial reduced its Gilead Sciences (GILD) stake by 6.6% in Q1 2026, selling an estimated $9.94M and leaving 1,011,564 shares worth $141M. The position accounts for 0.04% of the portfolio, ranked #449.

LPL Financial first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • LPL Financial held 1,011,564 shares of Gilead Sciences worth $141M as of Q1 2026.
  • LPL Financial sold 70,950 Gilead Sciences shares in Q1 2026, an estimated $9.94M.
  • Gilead Sciences made up 0.04% of LPL Financial's portfolio in Q1 2026, its #449 holding.
  • LPL Financial first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.